• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Virdante Pharmaceuticals

edit

Virdante Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes drugs for autoimmune and inflammatory diseases. It offers antibody and Fc-fusion drugs to treat auto-immune diseases. The company was formerly known as Centaurus Pharmaceuticals and changed its name to Virdante Pharmaceuticals, Inc. in April, 2008. The company was founded in 2007 and is based in Cambridge, Massachusetts.

Milestones

edit

• 
  Virdante Pharmaceuticals added Jeffrey V. Ravetch as Scientific Founder and Chairman of the Scientific Advisory Board.
  Posted 10/29/09 at 6:27pm
• 
  Virdante Pharmaceuticals added John Ripple as CEO.
  Posted 10/29/09 at 6:27pm
• 
  Virdante Pharmaceuticals received $30M in Series A funding. (11/25/09)
  Posted 10/29/09 at 6:27pm via onbiovc.com

Videos

Screenshots

edit

Sources

1. Virdante Pharmaceuticals, Inc.: Series A $30M (onbiovc.com) [edit]